(5α)-17-Methyl-6-oxo-4,5-epoxymorphinan-3-yl β-D-glucopyranosiduronic acid
Modify Date: 2024-01-10 11:50:48
(5α)-17-Methyl-6-oxo-4,5-epoxymorphinan-3-yl β-D-glucopyranosiduronic acid structure
|
Common Name | (5α)-17-Methyl-6-oxo-4,5-epoxymorphinan-3-yl β-D-glucopyranosiduronic acid | ||
|---|---|---|---|---|
| CAS Number | 40505-76-8 | Molecular Weight | 461.462 | |
| Density | 1.6±0.1 g/cm3 | Boiling Point | 744.5±60.0 °C at 760 mmHg | |
| Molecular Formula | C23H27NO9 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 404.0±32.9 °C | |
| Symbol |
GHS02, GHS06, GHS08 |
Signal Word | Danger | |
| Name | (5α)-17-Methyl-6-oxo-4,5-epoxymorphinan-3-yl β-D-glucopyranosiduronic acid |
|---|---|
| Synonym | More Synonyms |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Boiling Point | 744.5±60.0 °C at 760 mmHg |
| Molecular Formula | C23H27NO9 |
| Molecular Weight | 461.462 |
| Flash Point | 404.0±32.9 °C |
| Exact Mass | 461.168579 |
| LogP | -1.39 |
| Vapour Pressure | 0.0±2.6 mmHg at 25°C |
| Index of Refraction | 1.702 |
| Symbol |
GHS02, GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H226-H301 + H311 + H331-H370 |
| Precautionary Statements | P260-P280-P301 + P310-P311 |
| RIDADR | UN 1993C 3 / PGIII |
| Morphinan-6-one, 4,5-epoxy-3-(β-D-glucopyranuronosyloxy)-17-methyl-, (5α)- |
| MFCD00272664 |
| (5α)-17-Methyl-6-oxo-4,5-epoxymorphinan-3-yl β-D-glucopyranosiduronic acid |